X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3199) 3199
Publication (565) 565
Book Review (96) 96
Book Chapter (58) 58
Book / eBook (15) 15
Conference Proceeding (8) 8
Dissertation (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2035) 2035
humans (1959) 1959
oncology (1528) 1528
cancer (1313) 1313
metastatic melanoma (1214) 1214
animals (1027) 1027
immunotherapy (937) 937
metastasis (854) 854
tumors (724) 724
melanoma (683) 683
immunology (573) 573
female (554) 554
research (547) 547
care and treatment (526) 526
tumor microenvironment (494) 494
mice (462) 462
chemotherapy (446) 446
review (434) 434
cell line, tumor (401) 401
health aspects (400) 400
article (383) 383
cell biology (380) 380
male (367) 367
cancer therapies (335) 335
medicine, research & experimental (333) 333
breast cancer (328) 328
expression (328) 328
metastases (321) 321
metastatic breast-cancer (306) 306
dendritic cells (303) 303
neoplasms - immunology (294) 294
angiogenesis (290) 290
breast-cancer (290) 290
development and progression (283) 283
neoplasms - therapy (283) 283
metastatic colorectal-cancer (282) 282
lymphocytes (277) 277
pharmacology & pharmacy (270) 270
therapy (270) 270
antineoplastic agents - therapeutic use (260) 260
in-vivo (252) 252
neoplasm metastasis (250) 250
t cells (250) 250
analysis (249) 249
apoptosis (247) 247
survival (244) 244
gene expression (243) 243
medicine (240) 240
genetic aspects (233) 233
neoplasms - pathology (231) 231
proteins (230) 230
prognosis (229) 229
regulatory t-cells (225) 225
immunotherapy - methods (223) 223
biochemistry & molecular biology (222) 222
antigens (215) 215
middle aged (215) 215
neoplasms. tumors. oncology. including cancer and carcinogens (215) 215
patients (212) 212
neoplasms - drug therapy (208) 208
clinical trials (206) 206
melanoma - pathology (205) 205
research article (202) 202
tumor-infiltrating lymphocytes (201) 201
drug therapy (200) 200
t-cells (196) 196
medical prognosis (195) 195
biomarkers (194) 194
aged (193) 193
physiological aspects (190) 190
endothelial growth-factor (188) 188
mutation (187) 187
immune system (186) 186
biotechnology & applied microbiology (184) 184
medical research (182) 182
cell lung-cancer (181) 181
ipilimumab (181) 181
antineoplastic agents - pharmacology (180) 180
multidisciplinary sciences (178) 178
treatment outcome (178) 178
signal transduction (177) 177
adult (172) 172
melanoma - drug therapy (171) 171
microenvironment (171) 171
cells (170) 170
open-label (169) 169
melanoma - immunology (166) 166
biology (165) 165
t-lymphocytes - immunology (165) 165
immune response (164) 164
antibodies, monoclonal - therapeutic use (160) 160
cytokines (160) 160
studies (158) 158
kinases (157) 157
cytotoxicity (155) 155
usage (154) 154
stem cells (151) 151
growth (150) 150
colorectal cancer (149) 149
phase-ii trial (148) 148
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3228) 3228
French (16) 16
German (2) 2
Polish (2) 2
Arabic (1) 1
Chinese (1) 1
Japanese (1) 1
Korean (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Immunology, Immunotherapy, ISSN 0340-7004, 7/2012, Volume 61, Issue 7, pp. 1019 - 1031
Ipilimumab, a fully human monoclonal antibody specific to CTLA-4, has been shown to improve overall survival in metastatic melanoma patients. As a consequence... 
Cytotoxic T lymphocyte antigen-4 | Metastatic melanoma | Immunology | Medicine & Public Health | Gene expression profiling | Ipilimumab | Immunotherapy | Cancer Research | Oncology | ACTIVATION | MALIGNANT-MELANOMA | IMMUNOLOGY | IDENTIFICATION | CANCER | T-CELL RESPONSES | INTERFERON-GAMMA | ONCOLOGY | GENE-EXPRESSION | CHEMOKINE | BLOCKADE | Skin Neoplasms - pathology | Skin Neoplasms - drug therapy | Gene Expression - drug effects | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Gene Expression Profiling | Melanoma - pathology | Tumor Microenvironment - immunology | Neoplasm Metastasis | Biopsy | Melanoma - genetics | Melanoma - immunology | Melanoma - drug therapy | Skin Neoplasms - genetics | Survival Analysis | Neoplasm Staging | Antibodies, Monoclonal - immunology | Lymphocytes, Tumor-Infiltrating - immunology | Viral antibodies | Antigens | Anopheles | Lymphocytes | Genes | Melanoma | Monoclonal antibodies | Antibodies | Metastasis | T cells | Gene expression | Tumors | Cell proliferation | Cell survival | Immune response | Immune response (cell-mediated) | Clinical trials | Lymphocytes T | Metastases | CTLA-4 protein | Cell activation | gamma -Interferon | Antitumor activity | Microenvironments
Journal Article
Journal Article
BBA - Reviews on Cancer, ISSN 0304-419X, 12/2013, Volume 1836, Issue 2, pp. 321 - 335
Journal Article
SCIENCE TRANSLATIONAL MEDICINE, ISSN 1946-6234, 08/2013, Volume 5, Issue 200
Tumor escape from immune-mediated destruction has been associated with immunosuppressive mechanisms that inhibit T cell activation. Although evidence for an... 
MEDICINE, RESEARCH & EXPERIMENTAL | METASTATIC MELANOMA | GENE SIGNATURE | RESPONSES | DENDRITIC CELLS | B16 MELANOMA | REJECTION | ANTITUMOR IMMUNITY | CLINICAL ACTIVITY | HOMEOSTATIC PROLIFERATION | CANCER | CELL BIOLOGY
Journal Article
Cancer Microenvironment, ISSN 1875-2292, 12/2015, Volume 8, Issue 3, pp. 125 - 158
Neutrophils are myeloid cells that constitute 50–70 % of all white blood cells in the human circulation. Traditionally, neutrophils are viewed as the first... 
Biochemistry, general | Biomedicine | Immunology | Pre-metastatic niche | Tumor Microenvironment | Cancer Research | Oncology | Neutrophil function | Biomedicine general | Chemokines | Cell Biology | Prevention | Jewish schools | Cancer | Tumors
Journal Article